Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
As a result of the COVID-19 crisis, consumers have become more informed, leading to continued benefits for dietary supplements. In 2023, combination dietary supplements dominate the market, accounting for a significant portion of overall value sales.…
After a sharp spike in growth in retail volume terms in 2020 following the outbreak of COVID-19, sales of dietary supplements with an immune system positioning continued to normalise in 2023. Ginseng, for instance, looks set to register a significant…
The popularity of dietary supplements continued unabated in 2023. Despite the easing of the pandemic, Poles remained keen to purchase such products in order to help boost their immune systems and to lead healthier lifestyles. Demographic trends, in…
Dietary supplements is set to see sales rise in current value terms while falling at constant 2023 prices in 2023. Rising unit prices due to inflation are a key factor in the current value growth. Moreover, there have been plenty of new product…
Post-pandemic habits are driving the growth of dietary supplements in 2023. During COVID-19, sales of dietary supplements increased in Estonia, with consumers seeking products to aid immunity and remain healthy, and sales continue to be supported by…
There is a growing focus on preventive healthcare in Egypt; consumers have become more occupied with ways to prevent illness and maintain their health, particularly following the outbreak of COVID-19. While many are keen to reduce the risk of chronic…
Dermatologicals is projected to continue to post strong retail current value growth in 2023. Increasing retail value sales have, on the one hand, been influenced by rising unit prices, amid a highly inflationary climate. In addition, hair loss…
After recording strong growth in 2022, sales of many dermatologicals in 2023 are weakening. Declining disposable incomes due to elevated inflation and higher interest rates are eroding the interest of Spaniards in spending on perceived non-essential…
In 2023, dermatologicals is set to return to solid current value growth, although performances are expected to vary widely across categories. For instance, hair loss treatments is expected to continue to benefit from consumers’ perception of their…
International players with broad portfolios continue to lead the way in dermatologicals, with Bayer Romania the top-ranked company. Bayer Romania’s Canesten, the best-selling product in both topical and vaginal antifungals, is expected to maintain…